A large-scale phase 2b/3 trial testing the efficacy of a novel drug designed to prevent HIV infection has been cut short due to a combination of positive early data and disruptions caused by the COVID ...
Obese and overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean percent changes in body weight from baseline ...
BEIJING and BRIDGEWATER, N.J., Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results